Author: George Wei, Director of Analytics, Experic
Accelerating analytical method development can significantly shorten drug development timelines and support early process scale-up and validation — but only if high performance and regulatory compliance are maintained. Experic combines deep expertise, advanced technologies, and a QbD-driven approach to deliver robust, phase-appropriate methods that evolve with each program from early development through commercialization.